For rule 64K-1.001, F.A.C., to repeal references to obsolete alerts and reports; for rule 64K-1.003, F.A.C., to update the user agreement language and clarify when an agency administrator can remove certification requirements; for rule 64K-1.004, F....  

  •  

    DEPARTMENT OF HEALTH

    Prescription Drug Monitoring Program

    RULE NO.:RULE TITLE:

    64K-1.001Patient Advisory Alerts and Reports

    64K-1.003Accessing Database

    64K-1.004Management and Operation of Database

    64K-1.005Privacy of Controlled Substance Prescription Dispensing Information

    64K-1.007Indicators of Controlled Substance Abuse

    64K-1.008Electronic Health Recordkeeping System Integration

    PURPOSE AND EFFECT: For rule 64K-1.001, F.A.C., to repeal references to obsolete alerts and reports; for Rule 64K-1.003, F.A.C., to update the user agreement language and clarify when an agency administrator can remove certification requirements; for Rule 64K-1.004, F.A.C., to update the required reporting time period as required by recently enacted legislation and update the dispenser guide and clarify obligations of registered dispensing practitioners; for Rule 64K-1.005, F.A.C., to remove quarterly report requirement; for Rule 64K-1.007, F.A.C., to update the schedule of controlled substances required to be reported pursuant to recently enacted legislation; and for Rule 64K-1.008, F.A.C., to provide the process for approved entities to connect electronic health recordkeeping systems to the Prescription Drug Monitoring Program system as required by recently enacted legislation.

    SUBJECT AREA TO BE ADDRESSED: Prescription drug monitoring program operations and requirements.

    RULEMAKING AUTHORITY: 893.055 F.S.

    LAW IMPLEMENTED: 893.055 F.S.

    IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Rebecca Poston, Program Manager, Prescription Drug Monitoring program, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399 or Rebecca.Poston@FlHealth.gov.

     

    THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.